KRISHNA KITTU KOLLURI
CIK 1270521 · last filed 2026-08-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$502.70M
Companies
34
Total Filings
109
Lifetime Open-Market Net
$62.96M
Filer Profile
Related Filers
FOREST BASKETT — 40 joint filings, latest 2016-09-20
SCOTT D SANDELL — 39 joint filings, latest 2016-09-20
PETER J BARRIS — 36 joint filings, latest 2016-09-20
RYAN D DRANT — 31 joint filings, latest 2015-02-02
NEA 12 GP, LLC — 30 joint filings, latest 2016-09-20
NEA Partners 12, Limited Partnership — 30 joint filings, latest 2016-09-20
M JAMES BARRETT — 28 joint filings, latest 2016-06-14
New Enterprise Associates 12, Limited Partnership — 28 joint filings, latest 2016-09-20
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BLLN | Director | 69,189 | $123.08 | $8.52M | $0 | 4 | 2026-08-28 |
| Heliogen, Inc. (HLGN.WS) Delisted | 10%+ Owner | 753,396 | $0.02 | $14.0K | -$11.04M | 3 | 2022-08-22 |
| Achaogen, Inc. (AKAO) Delisted | 10%+ Owner | 5,215,128 | — | — | $6.75M | 1 | 2016-12-19 |
| Ra Pharmaceuticals, Inc. (RARX) Delisted | 10%+ Owner | 3,490,073 | — | — | $4.39M | 1 | 2016-10-31 |
| Roka BioScience, Inc. (ROKA) Delisted | 10%+ Owner | 321,681 | — | — | $4.60M | 3 | 2016-09-30 |
| Zosano Pharma Corp (ZSAN) Delisted | 10%+ Owner | 2,933 | $0.56 | $1.6K | -$44.8K | 1 | 2016-09-20 |
| KINETA, INC./DE (PTI) Delisted | 10%+ Owner | 177,730 | — | — | $48.00M | 1 | 2016-09-15 |
| ARDX | 10%+ Owner | 8,752,543 | $3.42 | $29.93M | $84.99M | 4 | 2016-07-20 |
| TESARO, Inc. (TSRO) Delisted | 10%+ Owner | 9,564,684 | — | — | $14.98M | 6 | 2016-03-18 |
| Epizyme, Inc. (EPZM) Delisted | 10%+ Owner | 5,854,351 | $1.47 | $8.61M | $23.95M | 5 | 2016-01-12 |
| SUPN | 10%+ Owner | 0 | $42.66 | $0 | $0 | 2 | 2015-11-12 |
| Avalo Therapeutics, Inc. (CERC.U) Delisted | 10%+ Owner | 594,245 | — | — | $0 | 1 | 2015-10-20 |
| SYNLOGIC, INC. (MIRN) Delisted | 10%+ Owner | 2,082,725 | — | — | $6.00M | 1 | 2015-10-06 |
| HIVE | Director | 943,034 | $3.16 | $2.98M | $0 | 1 | 2015-05-29 |
| BOX | 10%+ Owner | 0 | $31.39 | $0 | $0 | 1 | 2015-01-29 |
| Tableau Software Inc (DATA) Delisted | 10%+ Owner | 0 | — | — | -$58.41M | 5 | 2014-12-04 |
| CVENT INC (CVT) Delisted | 10%+ Owner | 65 | $8.52 | $554 | -$46.25M | 5 | 2014-11-28 |
| DERM | 10%+ Owner | 3,502,922 | $6.14 | $21.51M | $1.11M | 1 | 2014-10-08 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | 10%+ Owner | 22,942 | $18.62 | $427.2K | -$283.8K | 4 | 2014-08-29 |
| Loxo Oncology, Inc. (LOXO) Delisted | 10%+ Owner | 1,789,420 | — | — | $3.00M | 1 | 2014-08-06 |
| Care.com Inc (CRCM) Delisted | 10%+ Owner | 3,256,013 | — | — | $0 | 1 | 2014-01-29 |
| CHANNELADVISOR CORP (ECOM) Delisted | 10%+ Owner | 2,273,260 | $23.09 | $52.49M | $0 | 1 | 2014-01-28 |
| AUDIENCE INC (ADNC) Delisted | 10%+ Owner | 0 | — | — | $0 | 3 | 2013-12-16 |
| XOOM Corp (XOOM) Delisted | 10%+ Owner | 4,478,770 | — | — | $0 | 2 | 2013-10-31 |
| GRPN | 10%+ Owner | 20 | $21.30 | $426 | -$5.9K | 4 | 2013-09-18 |
| Clovis Oncology, Inc. (CLVS) Delisted | 10%+ Owner | 2,279,781 | $0.08 | $185.1K | $17.11M | 2 | 2013-06-05 |
| WDAY | 10%+ Owner | 2,321,212 | $189.45 | $439.75M | $0 | 2 | 2013-04-11 |
| Millennial Media Inc. (MM) Delisted | 10%+ Owner | 8,196,614 | — | — | -$21.48M | 2 | 2012-10-30 |
| FUSION-IO, INC. (FIO) Delisted | 10%+ Owner | 0 | — | — | -$43.38M | 15 | 2012-09-06 |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | 10%+ Owner | 2,884,221 | — | — | $5.00M | 1 | 2012-08-02 |
| INNERWORKINGS INC (INWK) Delisted | 10%+ Owner | 10,000 | — | — | -$12.62M | 11 | 2012-03-30 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | 10%+ Owner | 4,584,311 | $14.49 | $66.43M | $36.91M | 1 | 2012-03-09 |
| ECHO | 10%+ Owner | 97 | $90.11 | $8.7K | $0 | 1 | 2012-03-01 |
| ARYx Therapeutics, Inc. (ARYX) Delisted | 10%+ Owner | 0 | — | — | -$326.3K | 1 | 2011-03-14 |
Recent Filings · Page 8 of 11
109 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-10-30 | Millennial Media Inc. (MM) Delisted | Sell (S) | −1,597,787 | -$21.48M | EDGAR |
| 2012-10-18 | WDAY | Conv (C) | — | $0 | EDGAR |
| 2012-09-06 | FUSION-IO, INC. (FIO) Delisted | Mixed | −4,563,550 | -$1.79M | EDGAR |
| 2012-08-14 | FUSION-IO, INC. (FIO) Delisted | Gift (G) | −2,667 | $0 | EDGAR |
| 2012-08-02 | HYPERION THERAPEUTICS INC (HPTX) Delisted | Mixed | +2,880,287 | $5.00M | EDGAR |
| 2012-07-03 | TESARO, Inc. (TSRO) Delisted | Mixed | +11,499,255 | $15.00M | EDGAR |
| 2012-05-01 | FUSION-IO, INC. (FIO) Delisted | Other (J) | −68,310 | $0 | EDGAR |
| 2012-04-04 | Millennial Media Inc. (MM) Delisted | Conv (C) | +9,794,401 | $0 | EDGAR |
| 2012-03-30 | INNERWORKINGS INC (INWK) Delisted | Other (J) | −989,550 | $0 | EDGAR |
| 2012-03-30 | INNERWORKINGS INC (INWK) Delisted | Other (J) | −494,775 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.